Stay updated on Safety of HSC835 in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Safety of HSC835 in Hematological Malignancies Clinical Trial page.

Latest updates to the Safety of HSC835 in Hematological Malignancies Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a newer build of the page. No substantive content changes are indicated by this version update.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 on the page, reflecting a platform update.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows a new Revision: v3.5.3, replacing the previous v3.5.2. This indicates a minor site update.SummaryDifference0.1%

- Check55 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2. This update appears to be a version patch with no impact on study details or page content.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded three disease terms—Burkitt lymphoma, B-cell chronic lymphocytic leukemia, and acute lymphoid leukemia—to the study's keywords/MeSH terms to broaden indexing and searchability.SummaryDifference0.2%

- Check83 days agoChange DetectedSite revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Safety of HSC835 in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of HSC835 in Hematological Malignancies Clinical Trial page.